James Peyer - 27 Dec 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Erin Hoffert, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
27 Dec 2021
Net transactions value
+$19,674
Form type
4
Filing time
27 Dec 2021, 17:08:04 UTC
Previous filing
23 Dec 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $19,674 +3,712 +0.08% $5.30 4,837,998 27 Dec 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.